大暑
SciHub
文献互助
期刊查询
一搜即达
科研导航
即时热点
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!
greeeetwist
Lv7
4486 积分
2020-10-14 加入
最近求助
最近应助
互助留言
The Management of Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) With Biologics
27天前
已完结
Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials
27天前
已完结
Real-world outcomes in patients with hereditary angioedema prescribed lanadelumab versus other prophylaxis
1个月前
已完结
Real World treatment patterns of hereditary angioedema with lanadelumab in Germany: A prescription data analysis
1个月前
已完结
Real-world cohort study of adult and pediatric patients treated for hereditary angioedema in the United States
1个月前
已完结
Clinical efficacy of icatibant in the treatment of acute hereditary angioedema during the FAST-3 trial
1个月前
已完结
Clinical efficacy of icatibant in the treatment of acute hereditary angioedema during the FAST-3 trial
1个月前
已关闭
Icatibant for Multiple Hereditary Angioedema Attacks across the Controlled and Open-Label Extension Phases of FAST-3
1个月前
已完结
Treatment of hereditary angioedema with icatibant: Efficacy in clinical trials versus effectiveness in the real-world setting
1个月前
已完结
Randomized placebo-controlled trial of the bradykinin B2 receptor antagonist icatibant for the treatment of acute attacks of hereditary angioedema: the FAST-3 trial
1个月前
已完结
没有进行任何应助
帮大忙了
27天前
帮大忙了
1个月前
感谢
1个月前
速度真快
1个月前
速度真快
1个月前
速度真快
1个月前
不需要了【积分已退回】
3个月前
不需要了【积分已退回】
8个月前
感谢
8个月前
感谢
9个月前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论